Literature DB >> 6204802

Expression of HLA-DR (Ia like) antigen on epidermal keratinocytes in human dermatoses.

I A Lampert.   

Abstract

Ia antigen (HLA-DR in man) has been demonstrated in keratinocytes in graft versus host disease. This study investigates the occurrence of HLA-DR in keratinocytes in the following dermatoses: eczematous dermatitis, discoid lupus erythematosus, with immunoglobulin and non-exposed skin from cases of systemic lupus erythematosus with immunoglobulin deposits, lichen planus, lichen simplex, bullous pemphigoid, pemphigus vulgaris, 'toxic erthema', tuberculid and chillblain. Keratinocyte staining was found in a variety of conditions. The unifying features of the instances of its occurrence was lymphoid infiltration and usually some focal evidence of keratinocyte damage. Thus in eczema the staining was mid-epidermal, while in discoid lupus erythematosus and lichen planus it was basal. HLA-DR staining was absent in bullous pemphigoid and pemphigus vulgaris, which is consistent with the hypothesis that in these conditions the damage is mediated by autoantibodies and complement in the absence of cellular immune attack.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6204802      PMCID: PMC1536090     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  The human thymic microenvironment: an immunohistologic study.

Authors:  G Janossy; J A Thomas; F J Bollum; S Granger; G Pizzolo; K F Bradstock; L Wong; A McMichael; K Ganeshaguru; A V Hoffbrand
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

Review 2.  Origin and function of epidermal Langerhans cells.

Authors:  G Stingl; K Tamaki; S I Katz
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

3.  Expression of Ia antigen on epidermal keratinocytes is a consequence of cellular immunity.

Authors:  A J Suitters; I A Lampert
Journal:  Br J Exp Pathol       Date:  1982-04

4.  Expression of Ia antigen on epidermal keratinocytes in graft-versus-host disease.

Authors:  I A Lampert; A J Suitters; P M Chisholm
Journal:  Nature       Date:  1981 Sep 10-16       Impact factor: 49.962

5.  Graft-versus-host disease induces expression of Ia antigen in rat epidermal cells and gut epithelium.

Authors:  D W Mason; M Dallman; A N Barclay
Journal:  Nature       Date:  1981 Sep 10-16       Impact factor: 49.962

6.  Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum.

Authors:  J R Schiltz; B Michel
Journal:  J Invest Dermatol       Date:  1976-08       Impact factor: 8.551

7.  Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease.

Authors:  W S Selby; G Janossy; D Y Mason; D P Jewell
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

8.  Immuno-histochemical characterisation of cells involved in dermatopathic lymphadenopathy.

Authors:  I A Lampert; G Pizzolo; A Thomas; G Janossy
Journal:  J Pathol       Date:  1980-06       Impact factor: 7.996

9.  The pathogenic mechanisms of blister formation in bullous pemphigoid.

Authors:  K Naito; S Morioka; H Ogawa
Journal:  J Invest Dermatol       Date:  1982-11       Impact factor: 8.551

10.  Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells.

Authors:  H S Ko; S M Fu; R J Winchester; D T Yu; H G Kunkel
Journal:  J Exp Med       Date:  1979-08-01       Impact factor: 14.307

View more
  23 in total

1.  T lymphocytes expressing HECA-452 epitope are present in cutaneous acute graft-versus-host disease and erythema multiforme, but not in acute graft-versus-host disease in gut organs.

Authors:  R E Davis; B R Smoller
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

2.  MHC class II antigen expression in normal human epidermis.

Authors:  M M Carr; E McVittie; K Guy; D J Gawkrodger; J A Hunter
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

3.  Langerhans cells in human allergic contact dermatitis contain varying numbers of Birbeck granules. Double staining immunohistochemistry with OKT6 and Lag antibody.

Authors:  M Fujita; M Kashihara-Sawami; Y Horiguchi; F Furukawa; M Ueda; S Imamura
Journal:  Histochemistry       Date:  1990

4.  Induction of Thy-1 antigen on murine keratinocytes.

Authors:  A Scheynius; L Klareskog; R Holmdahl; P Larsson
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

5.  Epidermis and lymphocyte interactions during a tuberculin skin reaction. I. Increased ETAF/IL-1 like activity, expression of tissue antigens and mixed skin lymphocyte reactivity.

Authors:  C G Larsen; T Ternowitz; F G Larsen; K Thestrup-Pedersen
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

6.  Tumor necrosis factor-alpha inhibits cell proliferation and induces class II antigens and cell adhesion molecules in cultured normal human keratinocytes in vitro.

Authors:  M Detmar; C E Orfanos
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

7.  The expression of class II MHC gene products by fallopian tube epithelium in pregnancy and throughout the menstrual cycle.

Authors:  J N Bulmer; U Earl
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

8.  HLA-DR and HLA-DQ antigen expression of anagen and telogen hair bulbs in long-standing alopecia areata.

Authors:  H Hamm; S Klemmer; I Kreuzer; P M Steijlen; R Happle; E B Bröcker
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

9.  Expression of MHC class II antigens on bile duct epithelium in experimental graft versus host disease.

Authors:  L Takács; B Szende; A Rot; T Diamanstein
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

10.  HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx.

Authors:  F Esteban; F Ruiz-Cabello; A Concha; M Pérez-Ayala; J A Sánchez-Rozas; F Garrido
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.